Patents by Inventor Yoshinori Sakata

Yoshinori Sakata has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11234962
    Abstract: An object of the present invention is to provide a pharmaceutical composition comprising 1-(3-(2-(1-benzothiophen-5-yl)ethoxy)propyl)azetidin-3-ol or a salt thereof at a high concentration, with a characteristic bitter taste masked, and a manufacturing method thereof. The present invention provides a pharmaceutical composition comprising fine granules having a core comprising 1-(3-(2-(1-benzothiophen-5-yl)ethoxy)propyl)azetidin-3-ol or a salt thereof, and a binder; and a polymer layer with which a surface of the core is coated, wherein the fine granules have a roundness of 0.8 or more and a content of 1-(3-(2-(1-benzothiophen-5-yl)ethoxy)propyl)azetidin-3-ol or the salt thereof in the fine granules is 30 to 90% by mass.
    Type: Grant
    Filed: December 28, 2017
    Date of Patent: February 1, 2022
    Assignee: FUJIFILM Toyama Chemical Co., Ltd.
    Inventors: Kotaro Okada, Yoshinori Sakata, Shigetomo Tsujihata
  • Patent number: 10849880
    Abstract: An object of the present invention is to provide a solid pharmaceutical composition which suppresses the characteristic bitter taste of 1-(3-(2-(1-benzothiophen-5-yl)ethoxy)propyl)azetidin-3-ol or a salt thereof and has a good storage stability of the-aforementioned compound or a salt thereof. The present invention provides a solid pharmaceutical composition comprising 1-(3-(2-(1-benzothiophen-5-yl)ethoxy)propyl)azetidin-3-ol or a salt thereof and a carboxylic acid whose solubility in water at 25° C. is 50 g/100 g H2O or less, wherein pH of a solution obtained when the solid pharmaceutical composition is dissolved or suspended in a 10 mmol/L KCl solution such that 1-(3-(2-(1-benzothiophen-5-yl)ethoxy)propyl)azetidin-3-ol or the salt thereof is 1 mg/mL or 8.96 mg/mL is 4.8 or less.
    Type: Grant
    Filed: December 28, 2017
    Date of Patent: December 1, 2020
    Assignee: FUJIFILM Toyama Chemical Co., Ltd.
    Inventors: Kotaro Okada, Yoshinori Sakata, Shigetomo Tsujihata
  • Publication number: 20190343795
    Abstract: An object of the present invention is to provide a pharmaceutical composition comprising 1-(3-(2-(1-benzothiophen-5-yl)ethoxy)propyl)azetidin-3-ol or a salt thereof at a high concentration, with a characteristic bitter taste masked, and a manufacturing method thereof. The present invention provides a pharmaceutical composition comprising fine granules having a core comprising 1-(3-(2-(1-benzothiophen-5-yl)ethoxy)propyl)azetidin-3-ol or a salt thereof, and a binder; and a polymer layer with which a surface of the core is coated, wherein the fine granules have a roundness of 0.8 or more and a content of 1-(3-(2-(1-benzothiophen-5-yl)ethoxy)propyl)azetidin-3-ol or the salt thereof in the fine granules is 30 to 90% by mass.
    Type: Application
    Filed: December 28, 2017
    Publication date: November 14, 2019
    Applicant: FUJIFILM Toyama Chemical Co., Ltd.
    Inventors: Kotaro OKADA, Yoshinori SAKATA, Shigetomo TSUJIHATA
  • Publication number: 20190336476
    Abstract: The object of the present invention is to provide a solid pharmaceutical composition in which both the pre-bitter taste and the post-bitter taste of 1-(3-(2-(1-benzothiophen-5-yl)ethoxy)propyl)azetidin-3-ol or a salt thereof are suppressed. The present invention provides a solid pharmaceutical composition comprising 1-(3-(2-(1-benzothiophen-5-yl)ethoxy)propyl)azetidin-3-ol or a salt thereof and a compound having at least one hydrocarbon group having 8 to 18 carbon atoms and a sulfo group or a salt thereof.
    Type: Application
    Filed: December 28, 2017
    Publication date: November 7, 2019
    Applicant: FUJIFILM Toyama Chemical Co., Ltd.
    Inventors: Kotaro OKADA, Yoshinori SAKATA, Shigetomo TSUJIHATA
  • Publication number: 20190336477
    Abstract: An object of the present invention is to provide a solid pharmaceutical composition which suppresses the characteristic bitter taste of 1-(3-(2-(1-benzothiophen-5-yl)ethoxy)propyl)azetidin-3-ol or a salt thereof and has a good storage stability of the-aforementioned compound or a salt thereof. The present invention provides a solid pharmaceutical composition comprising 1-(3-(2-(1-benzothiophen-5-yl)ethoxy)propyl)azetidin-3-ol or a salt thereof and a carboxylic acid whose solubility in water at 25° C. is 50 g/100 g H2O or less, wherein pH of a solution obtained when the solid pharmaceutical composition is dissolved or suspended in a 10 mmol/L KCl solution such that 1-(3-(2-(1-benzothiophen-5-yl)ethoxy)propyl)azetidin-3-ol or the salt thereof is 1 mg/mL or 8.96 mg/mL is 4.8 or less.
    Type: Application
    Filed: December 28, 2017
    Publication date: November 7, 2019
    Applicant: FUJIFILM Toyama Chemical Co., Ltd.
    Inventors: Kotaro OKADA, Yoshinori SAKATA, Shigetomo TSUJIHATA
  • Publication number: 20170304196
    Abstract: An orally disintegrating tablet including: fine granules, each fine granule having, at its center, an active pharmaceutical ingredient-containing core that includes butylscopolamine bromide and water-insoluble particles, and having an intermediate layer that includes water-insoluble particles and coats the active pharmaceutical ingredient-containing core, and a bitterness-masking layer that includes talc and at least one water-insoluble polymer, in sequence from the active pharmaceutical ingredient-containing core side; and an excipient component positioned on the outside of the fine granules, and a method for producing the same.
    Type: Application
    Filed: July 11, 2017
    Publication date: October 26, 2017
    Inventors: Kotaro OKADA, Hisahiro MORI, Shigetomo TSUJIHATA, Yoshinori SAKATA
  • Publication number: 20170196807
    Abstract: Provided are a propofol-containing oil-in-water emulsion composition having high stability even in a case in which the emulsion composition is charged into a plastic container; and a method for producing the same. Provided is a propofol-containing oil-in-water emulsion composition including at least one selected from the group consisting of trishydroxymethylaminomethane, phosphoric acid, and triethanolamine; propofol; an oily component; an emulsifier; and water, in which a dissolved oxygen concentration is 5 mg/L or less and an average emulsion particle size is 180 nm or less.
    Type: Application
    Filed: March 24, 2017
    Publication date: July 13, 2017
    Applicant: FUJIFILM Corporation
    Inventors: Yoshinori SAKATA, Yasuyuki IZUMI, Shigetomo TSUJIHATA
  • Publication number: 20060291491
    Abstract: A wireless LAN board includes a wired LAN connector connected to a wired LAN board, an antenna connecting terminal connected with an antenna for performing radio signal transmission/reception, a wired LAN section connected to the wired LAN connector to transmit/receive a data signal to/from the wired LAN board, a wireless LAN section connected to the antenna connecting terminal to transmit/receive a data signal to/from an external device with the use of a radio signal through the antenna, and a controller section connected to the wired LAN section and the wireless LAN section to control the wired LAN section and the wireless LAN section.
    Type: Application
    Filed: May 22, 2006
    Publication date: December 28, 2006
    Inventors: Yoshinori Sakata, Tomohiro Konishi, Keiichi Tsuchiya